Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-3,138
Closed -$702K 582
2025
Q1
$702K Sell
3,138
-462
-13% -$108K 0.08% 238
2024
Q4
$823K Buy
3,600
+41
+1% +$9.87K 0.09% 236
2024
Q3
$869K Buy
3,559
+1,500
+73% +$335K 0.1% 217
2024
Q2
$394K Sell
2,059
-531
-21% -$108K 0.08% 258
2024
Q1
$513K Buy
2,590
+1,190
+85% +$218K 0.1% 225
2023
Q4
$241K Sell
1,400
-336
-19% -$51.6K 0.04% 237
2023
Q3
$257K Buy
+1,736
New +$314K 0.08% 202

Other funds holding RMD

Norden Group's RMD Position: Q2 2025 in Review

Norden Group sold out of ResMed (RMD) in Q2 2025, closing a stake of 3,138 shares — an estimated $702K sold.

Norden Group first reported a position in RMD in Q3 2023 and held it in 7 quarters. The position peaked at $869K in Q3 2024. 919 funds tracked by Wall St. Rank hold RMD as of Q2 2025.

  • Norden Group reported no remaining ResMed position as of Q2 2025 after selling out during the quarter.
  • Norden Group sold 3,138 ResMed shares in Q2 2025, an estimated $702K.
  • Norden Group first reported a position in ResMed in Q3 2023 and held it in 7 quarters.
  • Norden Group's ResMed position peaked at $869K in Q3 2024.
  • 919 funds tracked by Wall St. Rank held ResMed as of Q2 2025.

Based on Norden Group's 13F filing for Q2 2025, filed 15 Jul 2025.